These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9743120)

  • 1. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo.
    Pooga M; Soomets U; Hällbrink M; Valkna A; Saar K; Rezaei K; Kahl U; Hao JX; Xu XJ; Wiesenfeld-Hallin Z; Hökfelt T; Bartfai T; Langel U
    Nat Biotechnol; 1998 Sep; 16(9):857-61. PubMed ID: 9743120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide nucleic acid smugglers.
    Prochiantz A
    Nat Biotechnol; 1998 Sep; 16(9):819-20. PubMed ID: 9743109
    [No Abstract]   [Full Text] [Related]  

  • 3. Intrathecal administration of PNA targeting galanin receptor reduces galanin-mediated inhibitory effect in the rat spinal cord.
    Rezaei K; Xu IS; Wu WP; Shi TJ; Soomets U; Land T; Xu XJ; Wiesenfeld-Hallin Z; Hökfelt T; Bartfai T; Langel U
    Neuroreport; 2001 Feb; 12(2):317-20. PubMed ID: 11209942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular delivery of a double-stranded oligonucleotide NFkappaB decoy by hybridization to complementary PNA linked to a cell-penetrating peptide.
    Fisher L; Soomets U; Cortés Toro V; Chilton L; Jiang Y; Langel U; Iverfeldt K
    Gene Ther; 2004 Aug; 11(16):1264-72. PubMed ID: 15292915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of antisense PNA oligomers to human galanin receptor type 1 mRNA.
    Kilk K; Elmquist A; Saar K; Pooga M; Land T; Bartfai T; Soomets U; Langel U
    Neuropeptides; 2004 Oct; 38(5):316-24. PubMed ID: 15464198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
    Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
    Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential membrane perturbation caused by the cell penetrating peptide Tp10 depending on attached cargo.
    Bárány-Wallje E; Gaur J; Lundberg P; Langel U; Gräslund A
    FEBS Lett; 2007 May; 581(13):2389-93. PubMed ID: 17485081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of third intracellular loop of galanin receptor type 1 in signal transduction.
    Rezaei K; Saar K; Soomets U; Valkna A; Näsman J; Zorko M; Akerman K; Schroeder T; Bartfai T; Langel U
    Neuropeptides; 2000 Feb; 34(1):25-31. PubMed ID: 10688965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin receptor subtypes and ligand binding.
    Florén A; Land T; Langel U
    Neuropeptides; 2000 Dec; 34(6):331-7. PubMed ID: 11162289
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity.
    Lu X; Mazarati A; Sanna P; Shinmei S; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):147-52. PubMed ID: 15944003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the peptide nucleic acids (PNA) length requirement for PNA binding-induced transcription and gene expression.
    Wang G; Jing K; Balczon R; Xu X
    J Mol Biol; 2001 Nov; 313(5):933-40. PubMed ID: 11700050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galanin receptor 1 is expressed in a subpopulation of glutamatergic interneurons in the dorsal horn of the rat spinal cord.
    Landry M; Bouali-Benazzouz R; André C; Shi TJ; Léger C; Nagy F; Hökfelt T
    J Comp Neurol; 2006 Nov; 499(3):391-403. PubMed ID: 16998907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrotestosterone as a selective cellular/nuclear localization vector for anti-gene peptide nucleic acid in prostatic carcinoma cells.
    Boffa LC; Scarfi S; Mariani MR; Damonte G; Allfrey VG; Benatti U; Morris PL
    Cancer Res; 2000 Apr; 60(8):2258-62. PubMed ID: 10786693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA hairpin invasion and ribosome elongation arrest by mixed base PNA oligomer.
    Dias N; Sénamaud-Beaufort C; Forestier El El; Auvin C; Hélène C; Ester Saison-Behmoaras T
    J Mol Biol; 2002 Jul; 320(3):489-501. PubMed ID: 12096905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of galanin-induced contraction in the rat myometrium.
    Niiro N; Nishimura J; Hirano K; Nakano H; Kanaide H
    Br J Pharmacol; 1998 Aug; 124(8):1623-32. PubMed ID: 9756377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and genomic organization of a novel receptor from Drosophila melanogaster structurally related to mammalian galanin receptors.
    Lenz C; Søndergaard L; Grimmelikhuijzen CJ
    Biochem Biophys Res Commun; 2000 Mar; 269(1):91-6. PubMed ID: 10694483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential galanin upregulation in dorsal root ganglia and spinal cord after graded single ligature nerve constriction of the rat sciatic nerve.
    Coronel MF; Brumovsky PR; Hökfelt T; Villar MJ
    J Chem Neuroanat; 2008 Jan; 35(1):94-100. PubMed ID: 17693056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal antisense effects of peptide-PNA conjugates.
    Good L; Awasthi SK; Dryselius R; Larsson O; Nielsen PE
    Nat Biotechnol; 2001 Apr; 19(4):360-4. PubMed ID: 11283595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and biochemical characterization of a recombinant human galanin GALR1 receptor: agonist character of chimeric galanin peptides.
    Fitzgerald LW; Patterson JP; Conklin DS; Horlick R; Largent BL
    J Pharmacol Exp Ther; 1998 Nov; 287(2):448-56. PubMed ID: 9808667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New high affinity peptide antagonists to the spinal galanin receptor.
    Xu XJ; Wiesenfeld-Hallin Z; Langel U; Bedecs K; Bartfai T
    Br J Pharmacol; 1995 Oct; 116(3):2076-80. PubMed ID: 8640348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.